about
Isolated extramedullary breast relapses in inv(16) positive and c-KIT negative acute myeloid leukemia after allogenic hematopoietic stem cell transplantation - description of two casesExpression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.Efficacy of neoadjuvant hypofractionated radiotherapy in patients with locally advanced myxoid liposarcoma.HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma.FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas."Double trouble" - synchronous mantle cell lymphoma and metastatic squamous cell carcinoma in an inguinal lymph node.A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classificationThe prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanomaAn updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanomaSerine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma CellsBenign-looking primary fibrosarcoma of the uterusSynthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancerSignificance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangementsQuiz. What is your diagnosis?
P50
Q33935391-F7EBE70E-75B3-45EF-ACD4-5FAAC26E5556Q38683489-32F3F1E1-6347-4FE8-AA6C-B62A0B19033DQ39806627-DB9E4153-51AD-4EAD-9987-3F02F833B796Q40827846-A18BDFD5-814E-4BDD-BCCE-0EF10FE770E5Q41050317-56EB0CA1-2B0F-4D60-8513-504CE0D2AB2EQ41111760-9FF7F0DA-6E3A-4264-BB07-E9E1616AD01DQ49830194-77C302AB-F586-4129-AED6-795175C37ED4Q52571251-88750933-4D85-451B-9D13-91197DE57B54Q59359057-272FA7ED-446E-4980-B3F0-4ED3D4611CA4Q89775808-93B7CF70-CC62-492B-836A-AD2923E4AFFBQ90032616-278DDC78-827C-45D8-A155-AE4CE246A3A8Q90073171-DFAAB5BD-6637-4348-9DE8-E2FADC592A77Q90301038-56F011C6-BE14-4428-95CB-421ADFE37E08Q92598503-AFBE8696-B578-4564-8470-17F804A37460Q94510145-B45BB0F6-3A76-420F-B40A-D9A22D398405Q95406036-864369B0-8695-4906-97B1-B1446050C355
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anna Szumera-Cieckiewicz
@en
Anna Szumera-Cieckiewicz
@nl
type
label
Anna Szumera-Cieckiewicz
@en
Anna Szumera-Cieckiewicz
@nl
prefLabel
Anna Szumera-Cieckiewicz
@en
Anna Szumera-Cieckiewicz
@nl
P31
P496
0000-0001-5028-3422